LAMEA Oncology/Anti-cancer drugs Market Report

Global and China LAMEA Oncology/Anti-cancer drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 28, 2022
  • PAGES：185
  • REPORT CODE：GMM1504233
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the LAMEA Oncology/Anti-cancer drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Eli lilly & Co

    • Johnson & Johnson

    • Celgene

    • Merck & Co

    • Amgen

    • Sanofi

    • GlaxoSmithKline

    • Novartis

    • Roche

    • Pfizer

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Blood Cancer

    • Breast Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Others

    Application:

    • Chemotherapy

    • Targeted Therapy

    • Immunotherapy (Biologic Therapy)

    • Hormonal Therapy

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 LAMEA Oncology/Anti-cancer drugs Industry Overview

      • 1.1.1 LAMEA Oncology/Anti-cancer drugs Market Scope and Market Segments

      • 1.1.2 LAMEA Oncology/Anti-cancer drugs Industry Characteristics

      • 1.1.3 Global and China LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China LAMEA Oncology/Anti-cancer drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Blood Cancer

      • 1.2.2 Breast Cancer

      • 1.2.3 Gastrointestinal Cancer

      • 1.2.4 Prostate Cancer

      • 1.2.5 Others

    • 1.3 Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Chemotherapy

      • 1.3.2 Targeted Therapy

      • 1.3.3 Immunotherapy (Biologic Therapy)

      • 1.3.4 Hormonal Therapy

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global LAMEA Oncology/Anti-cancer drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global LAMEA Oncology/Anti-cancer drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China LAMEA Oncology/Anti-cancer drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China LAMEA Oncology/Anti-cancer drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global LAMEA Oncology/Anti-cancer drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 LAMEA Oncology/Anti-cancer drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 LAMEA Oncology/Anti-cancer drugs Industry PEST Analysis

    • 2.3 LAMEA Oncology/Anti-cancer drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 LAMEA Oncology/Anti-cancer drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on LAMEA Oncology/Anti-cancer drugs Industry

    Chapter 3 Global and China LAMEA Oncology/Anti-cancer drugs Market, by Manufacturer

    • 3.1 Global and China LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China LAMEA Oncology/Anti-cancer drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China LAMEA Oncology/Anti-cancer drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China LAMEA Oncology/Anti-cancer drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China LAMEA Oncology/Anti-cancer drugs Market Top 3 Players

    Chapter 4 Global and China LAMEA Oncology/Anti-cancer drugs Market, by Type (2017-2028)

    • 4.1 LAMEA Oncology/Anti-cancer drugs Market Trend, by Type

    • 4.2 Global LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global LAMEA Oncology/Anti-cancer drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global LAMEA Oncology/Anti-cancer drugs Price Trend, by Type (2017-2028)

    • 4.3 China LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China LAMEA Oncology/Anti-cancer drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China LAMEA Oncology/Anti-cancer drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China LAMEA Oncology/Anti-cancer drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global LAMEA Oncology/Anti-cancer drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China LAMEA Oncology/Anti-cancer drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America LAMEA Oncology/Anti-cancer drugs Market Analysis

    • 7.1 North America LAMEA Oncology/Anti-cancer drugs Market, by Type

    • 7.2 North America LAMEA Oncology/Anti-cancer drugs Market, by Application

    • 7.3 North America LAMEA Oncology/Anti-cancer drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe LAMEA Oncology/Anti-cancer drugs Market Analysis

    • 8.1 Europe LAMEA Oncology/Anti-cancer drugs Market, by Type

    • 8.2 Europe LAMEA Oncology/Anti-cancer drugs Market, by Application

    • 8.3 Europe LAMEA Oncology/Anti-cancer drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC LAMEA Oncology/Anti-cancer drugs Market Analysis

    • 9.1 APAC LAMEA Oncology/Anti-cancer drugs Market, by Type

    • 9.2 APAC LAMEA Oncology/Anti-cancer drugs Market, by Application

    • 9.3 APAC LAMEA Oncology/Anti-cancer drugs Market Analysis and Forecast, by Country

      • 9.3.1 China LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina LAMEA Oncology/Anti-cancer drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China LAMEA Oncology/Anti-cancer drugs Company Profiles

      • 11.1 Eli lilly & Co

        • 11.1.1 Eli lilly & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.1.3 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Johnson & Johnson

        • 11.2.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.2.3 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Celgene

        • 11.3.1 Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Celgene LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.3.3 Celgene LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Merck & Co

        • 11.4.1 Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Merck & Co LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.4.3 Merck & Co LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Amgen

        • 11.5.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Amgen LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.5.3 Amgen LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Sanofi

        • 11.6.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Sanofi LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.6.3 Sanofi LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GlaxoSmithKline

        • 11.7.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.7.3 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Novartis

        • 11.8.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Novartis LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.8.3 Novartis LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Roche

        • 11.9.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Roche LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.9.3 Roche LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Pfizer

        • 11.10.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Pfizer LAMEA Oncology/Anti-cancer drugs Product Profiles, Application and Specification

        • 11.10.3 Pfizer LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 LAMEA Oncology/Anti-cancer drugs Industry Investment Prospect and Risk Assessment

    • 12.1 LAMEA Oncology/Anti-cancer drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 LAMEA Oncology/Anti-cancer drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Production Value and Growth Rate (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Production Value and Growth Rate (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Blood Cancer (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Breast Cancer (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Gastrointestinal Cancer (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Prostate Cancer (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Chemotherapy (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Targeted Therapy (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Hormonal Therapy (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China LAMEA Oncology/Anti-cancer drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China LAMEA Oncology/Anti-cancer drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China LAMEA Oncology/Anti-cancer drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China LAMEA Oncology/Anti-cancer drugs Market Share, by Manufacturer in 2021

    • Figure Global and China LAMEA Oncology/Anti-cancer drugs Market Share, by Manufacturer in 2022

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Volume, by Type (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Value, by Type (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Value Share, by Type (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Price Trend, by Type (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Volume, by Type (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Value, by Type (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Value Share, by Type (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Price Trend, by Type (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Volume, by Application (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Value, by Application (2017-2028)

    • Table Global LAMEA Oncology/Anti-cancer drugs Sales Value Share, by Application (2017-2028)

    • Figure Global LAMEA Oncology/Anti-cancer drugs Sales Value Share, by Application (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Volume, by Application (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Value, by Application (2017-2028)

    • Table China LAMEA Oncology/Anti-cancer drugs Sales Value Share, by Application (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Value Share, by Application (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America LAMEA Oncology/Anti-cancer drugs Sales Volume, by Type (2017-2028)

    • Table North America LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Table North America LAMEA Oncology/Anti-cancer drugs Sales Volume, by Application (2017-2028)

    • Table North America LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe LAMEA Oncology/Anti-cancer drugs Sales Volume, by Type (2017-2028)

    • Table Europe LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe LAMEA Oncology/Anti-cancer drugs Sales Volume, by Application (2017-2028)

    • Table Europe LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure France LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC LAMEA Oncology/Anti-cancer drugs Sales Volume, by Type (2017-2028)

    • Table APAC LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC LAMEA Oncology/Anti-cancer drugs Sales Volume, by Application (2017-2028)

    • Table APAC LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure India LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa LAMEA Oncology/Anti-cancer drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina LAMEA Oncology/Anti-cancer drugs Sales Value and Growth Rate (2017-2028)

    • Table Eli lilly & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli lilly & Co Product Profiles, Application and Specification

    • Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Product Profiles, Application and Specification

    • Table Celgene LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co Product Profiles, Application and Specification

    • Table Merck & Co LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US